Lebrikizumab Biosimilar – Research Grade [ICH5058]

ichorbio’s Tralokinumab Biosimilar is for Research Use Only (RUO) and not for therapeutic use.

IL-13

ichorbio’s biosimilars are available in the following sizes:
1mg, 5mg, 10mg, 20mg, 50mg, 100mg

Human IgG4P-Kappa

CHO Cells

Human

Detects human IL-13. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Lebrikizumab.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

5mg/ml

Sterile, preservative-free, solution in PBS. BSA and Azide free.

>95% by SDS-PAGE

≤ 1.0 EU/mg as determined by the LAL method

This antibody is stable for at least 4 weeks when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C or -80°C. Avoid repeated freeze thaw cycles.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.